EXELIXIS, INC. Logo

EXELIXIS, INC.

Oncology-focused biotech that discovers, develops, and commercializes cancer therapies.

EXEL | US

Overview

Corporate Details

ISIN(s):
US30161Q1040
LEI:
Country:
United States of America
Address:
1851 HARBOR BAY PARKWAY, 94502 ALAMEDA

Description

Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes therapies for cancer treatment. The company's primary commercial product is cabozantinib, a small molecule inhibitor marketed for multiple cancer indications, including neuroendocrine tumors and certain types of carcinoma. Leveraging a genomics-based approach, Exelixis advances a diverse pipeline of potential medicines. Its research and development programs encompass in-house small molecule discovery and an expanding portfolio of biotherapeutics, such as antibody-drug conjugates and bispecific antibodies. The company pursues both next-generation approaches to established targets and first-in-class opportunities to address unmet needs in oncology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2017-05-27 02:52
FORM 4
English 7.2 KB
2017-05-27 02:52
FORM 4
English 7.6 KB
2017-05-27 02:51
FORM 4
English 7.3 KB
2017-05-27 02:50
FORM 4
English 7.7 KB
2017-05-27 02:49
FORM 4
English 7.7 KB
2017-05-27 02:48
FORM 4
English 7.6 KB
2017-05-27 02:47
FORM 4
English 7.2 KB
2017-05-27 02:46
FORM 4
English 7.2 KB
2017-05-27 02:45
FORM 4
English 7.2 KB
2017-05-25 22:30
S-8
English 39.9 KB
2017-05-25 22:28
8-K
English 115.3 KB
2017-05-17 03:13
FORM 4
English 8.1 KB
2017-05-17 03:12
FORM 4
English 7.8 KB
2017-05-11 22:03
DEFA14A
English 13.0 KB
2017-05-11 22:02
8-K
English 11.2 KB

Automate Your Workflow. Get a real-time feed of all EXELIXIS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EXELIXIS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EXELIXIS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.